Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Textiles Press Releases.
Press releases published on June 12, 2025

NXP and Rimac Technology Co-Develop Centralized Vehicle Architecture for Advanced Domain and Zonal Control
Rimac Technology is the first to deploy NXP’s S32E2 real-time processor series in its upcoming next-generation ECU platform for software-defined vehicles (SDV) NXP and Rimac’s jointly developed centralized architecture consolidates more than 20 electronic …

Paras laillinen louhintavaihtoehto vuonna 2025: AIXA MIner on rekisteröity finanssivalvonnan verkoston (FinCen) valtiovarainministeriöön MSB-toiminnan harjoittamiseksi nyt.
Helsinki, June 12, 2025 (GLOBE NEWSWIRE) -- Vastauksena markkinoiden kasvavaan kysyntään AIXA Miner on lanseerannut uuden sukupolven tekoälyn pilvikaivosjärjestelmän, jonka tavoitteena on tulla erittäin tunnustetuksi Bitcoin-pilvikaivosalustaksi vuonna …

La meilleure option minière légale en 2025: AIXA MINer est enregistré auprès du département du Trésor du Financial Central Enforcement Network (FinCen) pour mener des activités MSB dès maintenant.
Paris, France, 12 juin 2025 (GLOBE NEWSWIRE) -- En réponse à la demande croissante du marché,AIXA Miner a lancé une nouvelle génération de système de cloud mining d'intelligence artificielle, visant à devenir une plate-forme de cloud mining Bitcoin …

Det beste alternativet for lovlig gruvedrift i 2025: AIXA MINer er registrert hos finansdepartementet i Financial Central Enforcement Network (FinCen) for å utføre MSB-aktiviteter nå.
Oslo, June 12, 2025 (GLOBE NEWSWIRE) -- Som svar på den økende etterspørselen i markedet, AIXA gruvearbeider har lansert en ny generasjon av kunstig intelligens cloud mining system, med sikte på å bli en høyt anerkjent Bitcoin cloud mining plattform i 2025 …

MEXC Unveils $100 Million Guardian Fund to Safeguard Users Against Security Threats
VICTORIA, Seychelles, June 12, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has unveiled a groundbreaking $100 million Guardian Fund to enhance user safety and trust across its platform. This fund is designed to provide a strong …

Enterome raises $19 million to fund clinical development of its OncoMimics™ immunotherapy to treat Follicular Lymphoma
Proceeds to fund Phase 1/2 trial of EO2463 OncoMimics™, as a monotherapy or in combination, to treat multiple forms of indolent non-Hodgkin lymphoma (iNHL) $9 million from new investor The Institute for Follicular Lymphoma Innovation (IFLI) $10 million …

Editas Medicine Reports Proprietary Targeted Lipid Nanoparticle Delivery in Non-Human Primates Enables In Vivo HBG1/2 Promoter Editing for Sickle Cell Disease and Beta Thalassemia at the European Hematology Association 2025 Congress in June
Achieved 58% mean editing at five months after a single dose using high efficiency HSC delivery, demonstrating therapeutically relevant editing levels using a clinically validated strategy. Achievement supports development of a novel, in vivo approach to …

SNIPR BIOME Announces First Patient Dosed in its Phase 1b Clinical Trial of SNIPR001 in Patients with Hematological Cancer
COPENHAGEN, Denmark, June 12, 2025 (GLOBE NEWSWIRE) -- SNIPR Biome ApS (“SNIPR”), the company pioneering the development of precision medicines using CRISPR technology for microbial gene therapy, today announced that the first patient has been dosed in its …

Amaroq lýkur vel heppnaðri hlutafjáraukningu
Reykjavík, June 12, 2025 (GLOBE NEWSWIRE) -- ÞESSI TILKYNNING OG UPPLÝSINGARNAR SEM HÉR BIRTAST ERU EKKI ÆTLAÐAR TIL ÚTGÁFU, BIRTINGAR EÐA DREIFINGAR, BEINT EÐA ÓBEINT, Í HEILD EÐA AÐ HLUTA, Í EÐA TIL BANDARÍKJANNA, ÁSTRALÍU, JAPAN, LÝÐVELDISINS SUÐUR- …

Results of Fundraising
Reykjavík, June 12, 2025 (GLOBE NEWSWIRE) -- THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES, AUSTRALIA, …

Grant Funding Investment at South Crofty Tin Project
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its 100% owned and permitted South Crofty tin …

Caledonia Mining Corporation Plc: Director/PDMR Shareholding Notification
ST HELIER, Jersey, June 12, 2025 (GLOBE NEWSWIRE) -- Caledonia Mining Corporation Plc (NYSE AMERICAN: CMCL; AIM: CMCL; VFEX: CMCL) ("Caledonia" or "the Company") announces that it received notification on June 11, 2025 from Mr Victor Gapare, an executive …

Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 European Hematology Association (EHA) Congress
Median duration of response in FELIX study now 42.6 months after an additional 11 months of follow up More than half of patients still in remission at 24 months 38% of ongoing responders did not receive any subsequent therapy by month 33 Results suggest a …

Diagonal Therapeutics to Present New Preclinical Data Demonstrating Disease-Modifying Potential of Receptor Clustering Antibody Approach in HHT at EHA 2025 Congress
Results demonstrate potential of Company’s clustering antibody approach to address key challenges in HHT disease manifestations: restoring ALK1-mediated cellular signaling, preventing and reversing arteriovenous malformations, and preventing HHT-associated …

Korean telco KT selects the Digital Vending Machine® from Bango to power next-gen subscription bundles
CAMBRIDGE, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- Bango PLC (AIM:BGO, OTCQX:BGOPF), the leader in subscription bundling, today announces a strategic partnership with KT, a leading telecommunications provider in the Republic of Korea, to deliver …

AB Science announces issuance of a Canadian patent protecting the composition of matter of AB8939, including its use in the treatment of acute myeloid leukemia, with protection until 2036
PRESS RELEASE AB SCIENCE ANNOUNCES ISSUANCE OF A CANADIAN PATENT PROTECTING THE COMPOSITION OF MATTER OF AB8939, INCLUDING ITS USE IN THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML), WITH PROTECTION UNTIL 2036 THIS PATENT COMPLETES INTELLECTUAL PROPERTY …

AB Science annonce la délivrance d’un brevet canadien protégeant la composition de matière d’AB8939, y compris son utilisation dans le traitement de la leucémie myéloide aigue, avec une protection jusqu’à 2036
COMMUNIQUÉ DE PRESSE AB SCIENCE ANNONCE LA DÉLIVRANCE D'UN BREVET CANADIEN PROTÉGEANT LA COMPOSITION DE MATIERE D’AB8939, Y COMPRIS SON UTILISATION DANS LE TRAITEMENT DE LA LEUCÉMIE MYÉLOÏDE AIGUË (LMA), AVEC UNE PROTECTION JUSQU'EN 2036 CE BREVET COMPLÈTE …

Aalberts N.V.: Aalberts successfully issues US Private Placement of USD 600 million
Utrecht, 12 June 2025 Aalberts announces the successful signing and closing of Note Purchase Agreements for its inaugural debt issuance in the US Private Placement (USPP) market, securing a total equivalent amount of approximately USD 600 million. The …

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity
Dapirolizumab pegol (DZP) showed efficacy across multiple clinical endpoints in the PHOENYCS GO study, including fatigue and measures of disease activity DZP showed consistent improvements in fatigue, a common and debilitating symptom of systemic lupus …

AstriVax Therapeutics Further Strengthens Team with the Appointment of Dieter Weinand as New Chair of the Board of Directors
US-based Dieter Weinand is the former CEO of Bayer Pharma with more than 25 years of experience as a senior business leader in the pharmaceutical industry The appointment comes as AstriVax Therapeutics matures as a clinical stage immunotherapy company with …